{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:26:52Z","timestamp":1786980412242,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00467-026-07274-x","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:45:02Z","timestamp":1774971902000},"page":"3287-3302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From mechanisms to clinical practice: a review of diuretic therapy in pediatric nephrology"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-0666","authenticated-orcid":false,"given":"Subhankar","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchismita","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shampa","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"7274_CR1","first-page":"S118","volume":"59","author":"G Eknoyan","year":"1997","unstructured":"Eknoyan G (1997) A history of edema and its management. Kidney Int Suppl 59:S118\u2013S126","journal-title":"Kidney Int Suppl"},{"issue":"12","key":"7274_CR2","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","volume":"20","author":"CT Supuran","year":"2010","unstructured":"Supuran CT (2010) Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 20:3467\u20133474. https:\/\/doi.org\/10.1016\/j.bmcl.2010.05.009","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"7274_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","volume":"43","author":"BL Carter","year":"2004","unstructured":"Carter BL, Ernst ME, Cohen JD (2004) Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 43:4\u20139. https:\/\/doi.org\/10.1161\/01.HYP.0000103632.19915.0E","journal-title":"Hypertension"},{"issue":"10","key":"7274_CR4","doi-asserted-by":"publisher","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","volume":"310","author":"X Huang","year":"2016","unstructured":"Huang X, Dorhout Mees E, Vos P, Hamza S, Braam B (2016) Everything we always wanted to know about furosemide but were afraid to ask. Am J Physiol Renal Physiol 310:F958\u2013F971. https:\/\/doi.org\/10.1152\/ajprenal.00476.2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 9","key":"7274_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.59556\/japi.72.0670","volume":"72","author":"D Solanki","year":"2024","unstructured":"Solanki D, Choudhary S, Vora A, Ghose T, Mantri RR, Modi N et al (2024) Loop diuretics: unique mechanism of action. J Assoc Physicians India 72(Suppl 9):14\u201315. https:\/\/doi.org\/10.59556\/japi.72.0670","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"7274_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jmms12010026","volume":"12","author":"N-M Blebea","year":"2025","unstructured":"Blebea N-M, Pu\u0219ca\u0219u C, \u0218tef\u0103nescu E, St\u0103nigu\u021b AM (2025) Diuretic therapy: mechanisms, clinical applications, and management. J Mind Med Sci 12:26. https:\/\/doi.org\/10.3390\/jmms12010026","journal-title":"J Mind Med Sci"},{"key":"7274_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41581-024-00892-4","volume":"21","author":"R Agarwal","year":"2025","unstructured":"Agarwal R, Verma A, Georgianos PI (2025) Diuretics in patients with chronic kidney disease. Nat Rev Nephrol 21:264\u2013278. https:\/\/doi.org\/10.1038\/s41581-024-00892-4","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"7274_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1124\/jpet.103.059139","volume":"308","author":"H Hasannejad","year":"2004","unstructured":"Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P et al (2004) Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 308:1021\u20131029. https:\/\/doi.org\/10.1124\/jpet.103.059139","journal-title":"J Pharmacol Exp Ther"},{"key":"7274_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrneph.2011.161","volume":"8","author":"DA Sica","year":"2011","unstructured":"Sica DA (2011) Diuretic use in kidney disease. Nat Rev Nephrol 8:100\u2013109. https:\/\/doi.org\/10.1038\/nrneph.2011.161","journal-title":"Nat Rev Nephrol"},{"key":"7274_CR10","doi-asserted-by":"publisher","unstructured":"Van Siang Lian Mang P, Hui JC, Tan RSJ, Hasan MS, Choo YM, Abosamak MF et al (2023) The diuretic effect of adding aminophylline or theophylline to furosemide in pediatric populations. Eur J Pediatr 182:1\u20138. https:\/\/doi.org\/10.1007\/s00431-022-04655-w","DOI":"10.1007\/s00431-022-04655-w"},{"issue":"5","key":"7274_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s40272-024-00641-x","volume":"26","author":"LM Kiesel","year":"2024","unstructured":"Kiesel LM, Bertsche A, Kiess W, Siekmeyer M, Bertsche T, Neininger MP (2024) Drug\u2013drug interactions involving high-alert medications in pediatric intensive care patients. Paediatr Drugs 26:619\u2013629. https:\/\/doi.org\/10.1007\/s40272-024-00641-x","journal-title":"Paediatr Drugs"},{"key":"7274_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S et al (2023) IPNA clinical practice recommendations for steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","journal-title":"Pediatr Nephrol"},{"key":"7274_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1546465","volume":"16","author":"I Idasiak-Piechocka","year":"2025","unstructured":"Idasiak-Piechocka I, Lewandowski D, \u015awigut W, Kalinowski J, Mikosza K, Suchowiejski P et al (2025) Effect of hypoalbuminemia on drug pharmacokinetics. Front Pharmacol 16:1546465. https:\/\/doi.org\/10.3389\/fphar.2025.1546465","journal-title":"Front Pharmacol"},{"key":"7274_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12098-020-03252-9","volume":"87","author":"J Meena","year":"2020","unstructured":"Meena J, Bagga A (2020) Management of edema in nephrotic syndrome. Indian J Pediatr 87:633\u2013640. https:\/\/doi.org\/10.1007\/s12098-020-03252-9","journal-title":"Indian J Pediatr"},{"issue":"Suppl 5","key":"7274_CR15","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1016\/j.kint.2024.11.007","volume":"107","author":"J Floege","year":"2025","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Nephrotic syndrome in children work group, Floege J, Gibson KL, Vivarelli M, Liew A, Radhakrishnan J, Rovin BH (2025) KDIGO clinical practice guideline for the management of nephrotic syndrome in children. Kidney Int 107(Suppl 5):S241\u2013S289. https:\/\/doi.org\/10.1016\/j.kint.2024.11.007","journal-title":"Kidney Int"},{"key":"7274_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","volume":"58","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I et al (2021) Steroid-sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:461\u2013481. https:\/\/doi.org\/10.1007\/s13312-021-2217-3","journal-title":"Indian Pediatr"},{"issue":"1","key":"7274_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s1058-9813(00)00058-8","volume":"12","author":"L Lowrie","year":"2000","unstructured":"Lowrie L (2000) Diuretic therapy of heart failure in infants and children. Prog Pediatr Cardiol 12:45\u201355. https:\/\/doi.org\/10.1016\/s1058-9813(00)00058-8","journal-title":"Prog Pediatr Cardiol"},{"key":"7274_CR18","unstructured":"World Health Organization. (2022).\u00a0National guideline for clinical management of Dengue. World Health Organization"},{"key":"7274_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00050.x","volume":"67","author":"R Agarwal","year":"2005","unstructured":"Agarwal R (2005) Hypertension and survival in chronic hemodialysis patients. Kidney Int 67:1\u201313. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00050.x","journal-title":"Kidney Int"},{"key":"7274_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70033","volume":"7","author":"BA Agyei","year":"2024","unstructured":"Agyei BA, Wiafe YA, Donkor A, Anyitey-Kokor IC, Yahya K, Sarfo FS (2024) Childhood predictors of cardiovascular disease risk. Health Sci Rep 7:e70033. https:\/\/doi.org\/10.1002\/hsr2.70033","journal-title":"Health Sci Rep"},{"key":"7274_CR21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR et al (2017) Screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https:\/\/doi.org\/10.1542\/peds.2017-1904","journal-title":"Pediatrics"},{"key":"7274_CR22","doi-asserted-by":"publisher","unstructured":"ESCAPE Trial Group; W\u00fchl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A et al (2009) Strict blood pressure control and progression of kidney failure in children. N Engl J Med 361:1639\u20131650. https:\/\/doi.org\/10.1056\/NEJMoa0902066","DOI":"10.1056\/NEJMoa0902066"},{"key":"7274_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration (2020) Global burden of chronic kidney disease. Lancet 395:709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"7274_CR24","first-page":"375","volume":"22","author":"N Behzadnia","year":"2023","unstructured":"Behzadnia N, Esmaeilinejad K, Rashid-Farokhi F, Pourdowlat G (2023) Factors contributing to pulmonary hypertension in hemodialysis. Tanaffos 22:375\u2013381","journal-title":"Tanaffos"},{"issue":"3","key":"7274_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ajkd.2006.12.012","volume":"49","author":"JL Bragg-Gresham","year":"2007","unstructured":"Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V et al (2007) Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 49:426\u2013431. https:\/\/doi.org\/10.1053\/j.ajkd.2006.12.012","journal-title":"Am J Kidney Dis"},{"key":"7274_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2215\/CJN.05080418","volume":"14","author":"S Sibbel","year":"2019","unstructured":"Sibbel S, Walker AG, Colson C, Tentori F, Brunelli SM, Flythe J (2019) Loop diuretics at dialysis initiation. Clin J Am Soc Nephrol 14:95\u2013102. https:\/\/doi.org\/10.2215\/CJN.05080418","journal-title":"Clin J Am Soc Nephrol"},{"key":"7274_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","volume":"59","author":"JF Medcalf","year":"2001","unstructured":"Medcalf JF, Harris KP, Walls J (2001) Diuretics and preservation of residual kidney function. Kidney Int 59:1128\u20131133. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.0590031128.x","journal-title":"Kidney Int"},{"key":"7274_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","volume":"7","author":"JM Testani","year":"2014","unstructured":"Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al (2014) Loop diuretic efficiency in heart failure. Circ Heart Fail 7:261\u2013270. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000895","journal-title":"Circ Heart Fail"},{"issue":"4S","key":"7274_CR29","first-page":"S1","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int Suppl 100(4S):S1\u2013S276","journal-title":"Kidney Int Suppl"},{"key":"7274_CR30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1681\/ASN.2008010092","volume":"19","author":"B Rodriguez-Iturbe","year":"2008","unstructured":"Rodriguez-Iturbe B, Musser JM (2008) Poststreptococcal glomerulonephritis. J Am Soc Nephrol 19:1855\u20131864. https:\/\/doi.org\/10.1681\/ASN.2008010092","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"7274_CR31","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2021) KDIGO guideline for blood pressure in CKD. Kidney Int 99(Suppl 3):S1\u2013S87. https:\/\/doi.org\/10.1016\/j.kint.2020.11.003","journal-title":"Kidney Int"},{"issue":"Suppl 4","key":"7274_CR32","first-page":"S117","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) (2024) Clinical practice guideline for CKD. Kidney Int 105(Suppl 4):S117\u2013S314","journal-title":"Kidney Int"},{"key":"7274_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A et al (2016) European Society of Hypertension guidelines for children and adolescents. J Hypertens 34:1887\u20131920. https:\/\/doi.org\/10.1097\/HJH.0000000000001039","journal-title":"J Hypertens"},{"key":"7274_CR34","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1186\/cc13015","volume":"17","author":"LS Chawla","year":"2013","unstructured":"Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD et al (2013) Furosemide stress test. Crit Care 17:R207. https:\/\/doi.org\/10.1186\/cc13015","journal-title":"Crit Care"},{"key":"7274_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12098-024-05401-w","volume":"92","author":"S Dyvik","year":"2025","unstructured":"Dyvik S, Toteja N, Mittal A, Chaudhary B, Didel S, Singh K et al (2025) Furosemide stress test and cystatin C in children. Indian J Pediatr 92:625\u2013631. https:\/\/doi.org\/10.1007\/s12098-024-05401-w","journal-title":"Indian J Pediatr"},{"key":"7274_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00467-024-06387-5","volume":"40","author":"S Krishnasamy","year":"2025","unstructured":"Krishnasamy S, Sinha A, Lodha R, Sankar J, Tarik M, Ramakrishnan L et al (2025) Furosemide stress test in critically ill children. Pediatr Nephrol 40:243\u2013251. https:\/\/doi.org\/10.1007\/s00467-024-06387-5","journal-title":"Pediatr Nephrol"},{"key":"7274_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196088","volume":"13","author":"T Bove","year":"2018","unstructured":"Bove T, Belletti A, Putzu A, Pappacena S, Denaro G, Landoni G et al (2018) Intermittent furosemide in AKI. PLoS One 13:e0196088. https:\/\/doi.org\/10.1371\/journal.pone.0196088","journal-title":"PLoS ONE"},{"key":"7274_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13613-022-01024-6","volume":"12","author":"S Wichmann","year":"2022","unstructured":"Wichmann S, Barbateskovic M, Liang N, Itenov TS, Berthelsen RE, Lindschou J et al (2022) Loop diuretics in ICU patients. Ann Intensive Care 12:52. https:\/\/doi.org\/10.1186\/s13613-022-01024-6","journal-title":"Ann Intensive Care"},{"key":"7274_CR39","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s12098-021-03727-3","volume":"88","author":"S Abraham","year":"2021","unstructured":"Abraham S, Rameshkumar R, Chidambaram M, Soundravally R, Subramani S, Bhowmick R et al (2021) Furosemide to prevent AKI in children. Indian J Pediatr 88:1099\u20131106. https:\/\/doi.org\/10.1007\/s12098-021-03727-3","journal-title":"Indian J Pediatr"},{"key":"7274_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2044.2009.06228.x","volume":"65","author":"KM Ho","year":"2010","unstructured":"Ho KM, Power BM (2010) Benefits and risks of furosemide in AKI. Anaesthesia 65:283\u2013293","journal-title":"Anaesthesia"},{"key":"7274_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s44253-023-00010-5","volume":"1","author":"S Vivek","year":"2023","unstructured":"Vivek S, Rameshkumar R, Muthu M, Karunakar P, Chidambaram M, Kumar CGD et al (2023) Furosemide use in pediatric ICU AKI. Intensive Care Med Paediatr Neonatal 1:6. https:\/\/doi.org\/10.1007\/s44253-023-00010-5","journal-title":"Intensive Care Med Paediatr Neonatal"},{"key":"7274_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014937.pub2","volume":"1","author":"H Hashimoto","year":"2025","unstructured":"Hashimoto H, Yamada H, Murata M, Watanabe N (2025) Diuretics for preventing and treating AKI. Cochrane Database Syst Rev 1:CD014937. https:\/\/doi.org\/10.1002\/14651858.CD014937.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"7274_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.7","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for AKI. Kidney Int Suppl 2:1\u2013138. https:\/\/doi.org\/10.1038\/kisup.2012.7","journal-title":"Kidney Int Suppl"},{"key":"7274_CR44","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2022.18331","volume":"328","author":"MD Walker","year":"2022","unstructured":"Walker MD, Shane E (2022) Hypercalcemia. JAMA 328:1624\u20131636. https:\/\/doi.org\/10.1001\/jama.2022.18331","journal-title":"JAMA"},{"key":"7274_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00345-025-05503-w","volume":"43","author":"L Yi","year":"2025","unstructured":"Yi L, Wang H, Ji Y et al (2025) Thiazide dosage for urolithiasis prevention. World J Urol 43:127. https:\/\/doi.org\/10.1007\/s00345-025-05503-w","journal-title":"World J Urol"},{"key":"7274_CR46","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/ndt\/gfaf003","volume":"40","author":"A B\u00f6kenkamp","year":"2025","unstructured":"B\u00f6kenkamp A, Ariceta G, B\u00f6ckenhauer D et al (2025) Dent disease recommendations. Nephrol Dial Transplant 40:852\u2013864. https:\/\/doi.org\/10.1093\/ndt\/gfaf003","journal-title":"Nephrol Dial Transplant"},{"key":"7274_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MOP.0000000000000473","volume":"29","author":"D Bockenhauer","year":"2017","unstructured":"Bockenhauer D, Bichet DG (2017) Nephrogenic diabetes insipidus. Curr Opin Pediatr 29:199\u2013205. https:\/\/doi.org\/10.1097\/MOP.0000000000000473","journal-title":"Curr Opin Pediatr"},{"key":"7274_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1479764","volume":"15","author":"K Flynn","year":"2025","unstructured":"Flynn K, Hatfield J, Brown K, Vietor N, Hoang T (2025) Central and nephrogenic diabetes insipidus. Front Endocrinol 15:1479764. https:\/\/doi.org\/10.3389\/fendo.2024.1479764","journal-title":"Front Endocrinol"},{"key":"7274_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41581-024-00897-z","volume":"21","author":"E Levtchenko","year":"2025","unstructured":"Levtchenko E, Ariceta G, Arguedas Flores O et al (2025) Congenital nephrogenic diabetes insipidus. Nat Rev Nephrol 21:83\u201396. https:\/\/doi.org\/10.1038\/s41581-024-00897-z","journal-title":"Nat Rev Nephrol"},{"key":"7274_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s40746-025-00347-3","volume":"12","author":"TD Nelin","year":"2026","unstructured":"Nelin TD, McGlynn JR, Greenberg RG et al (2026) What is the role of diuretics in the prevention and management of bronchopulmonary dysplasia? Curr Treat Options Pediatr 12:6. https:\/\/doi.org\/10.1007\/s40746-025-00347-3","journal-title":"Curr Treat Options Pediatr"},{"key":"7274_CR51","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/apa.17093","volume":"113","author":"E Briain","year":"2024","unstructured":"Briain E, Byrne AO, Dowling J, Kiernan J, Lynch JCR, Alomairi L et al (2024) Diuretics use in the management of bronchopulmonary dysplasia in preterm infants: a systematic review. Acta Paediatr 113:394\u2013402. https:\/\/doi.org\/10.1111\/apa.17093","journal-title":"Acta Paediatr"},{"key":"7274_CR52","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ph6091094","volume":"6","author":"GM Pacifici","year":"2013","unstructured":"Pacifici GM (2013) Furosemide in neonates. Pharmaceuticals (Basel) 6:1094\u20131129. https:\/\/doi.org\/10.3390\/ph6091094","journal-title":"Pharmaceuticals (Basel)"},{"key":"7274_CR53","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1345\/aph.1G693","volume":"40","author":"BE Gulbis","year":"2006","unstructured":"Gulbis BE, Spencer AP (2006) Continuous furosemide infusion after cardiac surgery. Ann Pharmacother 40:1797\u20131803. https:\/\/doi.org\/10.1345\/aph.1G693","journal-title":"Ann Pharmacother"},{"key":"7274_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1442-200X.2009.02886.x","volume":"52","author":"C Gimpel","year":"2010","unstructured":"Gimpel C, Krause A, Franck P, Krueger M, von Schnakenburg C (2010) Furosemide exposure and nephrocalcinosis in preterm infants. Pediatr Int 52:51\u201356. https:\/\/doi.org\/10.1111\/j.1442-200X.2009.02886.x","journal-title":"Pediatr Int"},{"key":"7274_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40748-018-0092-2","volume":"4","author":"W Jackson","year":"2018","unstructured":"Jackson W, Taylor G, Selewski D et al (2018) Furosemide and hearing loss in premature infants. Matern Health Neonatol Perinatol 4:23. https:\/\/doi.org\/10.1186\/s40748-018-0092-2","journal-title":"Matern Health Neonatol Perinatol"},{"key":"7274_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/eat.20814","volume":"44","author":"M Mascolo","year":"2011","unstructured":"Mascolo M, Chu ES, Mehler PS (2011) Diuretics in eating disorders. Int J Eat Disord 44:200\u2013202. https:\/\/doi.org\/10.1002\/eat.20814","journal-title":"Int J Eat Disord"},{"key":"7274_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/postgradmedj-2020-139701","volume":"98","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wong LYF, Cheung BMY (2022) Diuretic-induced hypokalaemia. Postgrad Med J 98:477\u2013482. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139701","journal-title":"Postgrad Med J"},{"key":"7274_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.ajkd.2019.07.011","volume":"75","author":"EJ Filippone","year":"2020","unstructured":"Filippone EJ, Ruzieh M, Foy A (2020) Thiazide-associated hyponatremia. Am J Kidney Dis 75:256\u2013264. https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.011","journal-title":"Am J Kidney Dis"},{"key":"7274_CR59","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1055\/s-0040-1722598","volume":"39","author":"M Harkin","year":"2022","unstructured":"Harkin M, Johnson PN, Neely SB, White L, Miller JL (2022) Chlorothiazide-induced hyponatremia in NICU. Am J Perinatol 39:1354\u20131361. https:\/\/doi.org\/10.1055\/s-0040-1722598","journal-title":"Am J Perinatol"},{"key":"7274_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101046","volume":"7","author":"A Albert","year":"2025","unstructured":"Albert A, Hinkel UP, Bohlender T, Stieger P, Braun-Dullaeus RC, Albert C (2025) Hypomagnesemia and parathyroid hormone secretion. Kidney Med 7:101046. https:\/\/doi.org\/10.1016\/j.xkme.2025.101046","journal-title":"Kidney Med"},{"key":"7274_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/children12111442","volume":"12","author":"J Dotis","year":"2025","unstructured":"Dotis J, Skarlatou A, Fourikou M, Papadopoulou A, Chochliourou E (2025) Furosemide-induced nephrocalcinosis in premature neonates. Children 12:1442. https:\/\/doi.org\/10.3390\/children12111442","journal-title":"Children"},{"issue":"Suppl","key":"7274_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1681\/ASN.20203110S167c","volume":"31","author":"Y Li","year":"2020","unstructured":"Li Y, Su L, Xu X (2020) Loop diuretics and hospital-acquired AKI. J Am Soc Nephrol 31(Suppl):67. https:\/\/doi.org\/10.1681\/ASN.20203110S167c","journal-title":"J Am Soc Nephrol"},{"key":"7274_CR63","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","volume":"56","author":"C Ben Salem","year":"2017","unstructured":"Ben Salem C, Slim R, Fathallah N, Hmouda H (2017) Drug-induced hyperuricaemia and gout. Rheumatology 56:679\u2013688. https:\/\/doi.org\/10.1093\/rheumatology\/kew293","journal-title":"Rheumatology"},{"key":"7274_CR64","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.36347\/sjams.2025.v13i08.003","volume":"13","author":"R Kumar","year":"2025","unstructured":"Kumar R, Gupta N, Aggarwal A, Goyal A (2025) Diuretic use and hearing loss. Sch J App Med Sci 13:1542\u20131548","journal-title":"Sch J App Med Sci"},{"key":"7274_CR65","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1044\/2024_AJA-24-00065","volume":"33","author":"S Rameshsankar","year":"2024","unstructured":"Rameshsankar S, Seethapathy J, Balakrishnan U (2024) Ototoxic drug exposure in neonates. Am J Audiol 33:1153\u20131164. https:\/\/doi.org\/10.1044\/2024_AJA-24-00065","journal-title":"Am J Audiol"},{"key":"7274_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.earlhumdev.2018.08.009","volume":"125","author":"LA Wang","year":"2018","unstructured":"Wang LA, Smith PB, Laughon M, Goldberg RN, Ku LC, Zimmerman KO et al (2018) Prolonged furosemide exposure and hearing screen abnormalities. Early Hum Dev 125:26\u201330. https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.08.009","journal-title":"Early Hum Dev"},{"key":"7274_CR67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1524-6175.2005.04105.x","volume":"7","author":"LM Prisant","year":"2005","unstructured":"Prisant LM, Chin E (2005) Gynecomastia and hypertension. J Clin Hypertens (Greenwich) 7:245\u2013248. https:\/\/doi.org\/10.1111\/j.1524-6175.2005.04105.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"7274_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-0034-1373845","volume":"32","author":"MM Laughon","year":"2015","unstructured":"Laughon MM, Chantala K, Aliaga S et al (2015) Diuretic exposure in premature infants. Am J Perinatol 32:49\u201356. https:\/\/doi.org\/10.1055\/s-0034-1373845","journal-title":"Am J Perinatol"},{"key":"7274_CR69","doi-asserted-by":"publisher","DOI":"10.13188\/2380-0534.1000039","volume":"9","author":"S Bhatia","year":"2023","unstructured":"Bhatia S, Abraham MJ, Mehdi MQ, Niebuhr B, Jain SK (2023) Diuretics and metabolic bone disease in preterm infants. J Pediatr Child Care 9:4","journal-title":"J Pediatr Child Care"},{"key":"7274_CR70","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00246-022-02983-0","volume":"44","author":"DM Newland","year":"2023","unstructured":"Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, Hong BJ (2023) Dapagliflozin in pediatric heart failure. Pediatr Cardiol 44:146\u2013152. https:\/\/doi.org\/10.1007\/s00246-022-02983-0","journal-title":"Pediatr Cardiol"},{"key":"7274_CR71","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ekir.2021.12.019","volume":"7","author":"J Liu","year":"2021","unstructured":"Liu J, Cui J, Fang X, Chen J, Yan W, Shen Q, Xu H (2021) Dapagliflozin in inherited proteinuric kidney disease. Kidney Int Rep 7:638\u2013641. https:\/\/doi.org\/10.1016\/j.ekir.2021.12.019","journal-title":"Kidney Int Rep"},{"key":"7274_CR72","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1007\/s00467-024-06481-8","volume":"39","author":"N Choi","year":"2024","unstructured":"Choi N, Kim JH, Park PG, Lee H, Min J, Park HW, Ahn YH, Kang HG (2024) Dapagliflozin in children with kidney disease. Pediatr Nephrol 39:3551\u20133558. https:\/\/doi.org\/10.1007\/s00467-024-06481-8","journal-title":"Pediatr Nephrol"},{"key":"7274_CR73","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1016\/j.ekir.2024.09.014","volume":"9","author":"J Boeckhaus","year":"2024","unstructured":"Boeckhaus J, Gale DP, Simon J, Ding J, Zhang Y, Bergmann C et al (2024) SGLT2 inhibition in Alport syndrome. Kidney Int Rep 9:3490\u20133500. https:\/\/doi.org\/10.1016\/j.ekir.2024.09.014","journal-title":"Kidney Int Rep"},{"key":"7274_CR74","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G et al (2017) Tolvaptan in later-stage ADPKD. N Engl J Med 377:1930\u20131942. https:\/\/doi.org\/10.1056\/NEJMoa1710030","journal-title":"N Engl J Med"},{"key":"7274_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2215\/CJN.0000000000000022","volume":"18","author":"D Mekahli","year":"2023","unstructured":"Mekahli D, Guay-Woodford LM, Cadnapaphornchai MA, Greenbaum LA, Litwin M, Seeman T et al (2023) Tolvaptan in children with ADPKD. Clin J Am Soc Nephrol 18:36\u201346. https:\/\/doi.org\/10.2215\/CJN.0000000000000022","journal-title":"Clin J Am Soc Nephrol"},{"key":"7274_CR76","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4274\/jcrpe.4531","volume":"9","author":"G Tuli","year":"2017","unstructured":"Tuli G, Tessaris D, Einaudi S, De Sanctis L, Matarazzo P (2017) Tolvaptan in pediatric SIADH. J Clin Res Pediatr Endocrinol 9:288\u2013292. https:\/\/doi.org\/10.4274\/jcrpe.4531","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"7274_CR77","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12098-021-03988-y","volume":"89","author":"J Meena","year":"2022","unstructured":"Meena J, Hari P, Sinha A, Bagga A (2022) Tolvaptan and furosemide in refractory nephrotic edema. Indian J Pediatr 89:699\u2013705. https:\/\/doi.org\/10.1007\/s12098-021-03988-y","journal-title":"Indian J Pediatr"},{"key":"7274_CR78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ped.12590","volume":"57","author":"D Hirano","year":"2015","unstructured":"Hirano D, Kakegawa D, Yamada A, Ito A, Miwa S, Ida H (2015) Tolvaptan in diuretic-resistant heart and kidney failure. Pediatr Int 57:183\u2013185. https:\/\/doi.org\/10.1111\/ped.12590","journal-title":"Pediatr Int"},{"key":"7274_CR79","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P et al (2020) Finerenone in chronic kidney disease and type 2 diabetes. N Engl J Med 383:2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"key":"7274_CR80","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P et al (2021) Cardiovascular events with finerenone. N Engl J Med 385:2252\u20132263. https:\/\/doi.org\/10.1056\/NEJMoa2110956","journal-title":"N Engl J Med"},{"key":"7274_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64640-3","volume":"16","author":"CA Wang","year":"2025","unstructured":"Wang CA, Lai HW, Chen JY, Wang WJ, Lin LC, Chiu YL, Cheng CY, Wu VC (2025) Finerenone versus spironolactone in CKD with diabetes. Nat Commun 16:9641. https:\/\/doi.org\/10.1038\/s41467-025-64640-3","journal-title":"Nat Commun"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07274-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07274-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07274-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:47:42Z","timestamp":1786978062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07274-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["7274"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07274-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}